JPRN-jRCT1071220039已完成未知
Administration study of Testosterone ester in healthy adult males
Yomenura Takuma0 个研究点目标入组 7 人开始时间: 2022年8月10日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 7
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 35age old（—）
- 性别
- Male
入选标准
- •Japanease with BMI 18.5 or more and less than 25.0 at the time of prior examination. Person who is judged by Principal investigator or Sub-investigator that there is no problem with participation in the test.
排除标准
- •1) A person who has caused allergic symptoms due to the study drug or the component of the study drug. 2) A person who is being treated for any disease or who may be treated during the test period. 3) A person suspected of having the following diseases or a person with a medical history. Androgen-dependent malignancies (eg prostate cancer), heart disease, renal disease, cancer. 4) Alcohol or drug dependents, depression or those with a medical history. 5) A person who used a medicinal or over-the-counter medication within 2 weeks of the scheduled administration of the study drug. 6) A person who has taken one or more supplements, foods containing Hyperethesia, grapefruit or their processed products within one week of the scheduled administration of the study drug. 7) A person who has received another investigational drug or investigational drug within 16 weeks of the scheduled study drug administration date, or an investigational drug or investigational drug containing an approved component within 12 weeks. 8) A person who received blood of 200 mL or more within 30 days of the scheduled administration of the study drug and 400 mL or more within 90 days and those who received blood donation of the component within 14 days of the scheduled administration. 9) A person who weighs less than 50 kg at the time of pre-examination. 10) A person who is confirmed negative by SARS-CoV-2 test or who are suspected of having a new coronavirus infection. 11) A person who has been judged by the Principal investigator or Sub-investigator to be inappropriate to participate in this test.
研究者
相似试验
进行中（未招募）
1 期
Does Testposterone improve the Pain Perception of Patients with Chronic Pain?Patient with persistent somatoform pain disorder (F45.40 or F45.41) should be included into the study.EUCTR2016-000048-32-DERWTH Aachen University/CTC-A60
已完成
不适用
Administration study on preparation of testosterone undecanoate to healthy adult malesJPRN-jRCT1071210006Yonemura Takuma8
已完成
4 期
Pharmacokinetics of Testosterone Cream Applied to Scrotal Skin in healthy male volunteersHealthy male volunteers - dose finding - testosterone pharmacologyOther - Research that is not of generic health relevance and not applicable to specific health categories listed aboveACTRN12615000045516Andrology Department, Concord Hospital12
招募中
3 期
Testosterone therapy for the treatment of nonalcoholic fatty liver diseaseNonalcoholic fatty liver diseaseACTRN12619000701123Austin Health120
进行中（未招募）
不适用
EFFECT OF TESTOSTERON THERAPY ON LOW URINARY TRACTmetabolic syndrome and BPH patients who will undergo simple prostatectomyMedDRA version: 14.1Level: LLTClassification code 10004447Term: Benign prostatic hypertrophySystem Organ Class: 100000004872EUCTR2012-003494-26-ITAZIENDA OSPEDALIERA UNIVERSITARIA CAREGGI